Awakn Life Sciences Stock Fundamentals
AWKNF Stock | USD 0.08 0.01 6.67% |
Awakn Life Sciences fundamentals help investors to digest information that contributes to Awakn Life's financial success or failures. It also enables traders to predict the movement of Awakn OTC Stock. The fundamental analysis module provides a way to measure Awakn Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Awakn Life otc stock.
Awakn |
Awakn Life Sciences OTC Stock Shares Outstanding Analysis
Awakn Life's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Awakn Life Shares Outstanding | 32.48 M |
Most of Awakn Life's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Awakn Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, Awakn Life Sciences has 32.48 M of shares currently outstending. This is 82.01% lower than that of the Healthcare sector and 69.61% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 94.32% higher than that of the company.
Awakn Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Awakn Life's current stock value. Our valuation model uses many indicators to compare Awakn Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Awakn Life competition to find correlations between indicators driving Awakn Life's intrinsic value. More Info.Awakn Life Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Awakn Life's earnings, one of the primary drivers of an investment's value.Awakn Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Awakn Life's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Awakn Life could also be used in its relative valuation, which is a method of valuing Awakn Life by comparing valuation metrics of similar companies.Awakn Life is currently under evaluation in shares outstanding category among its peers.
Awakn Fundamentals
Return On Equity | -2.84 | |||
Return On Asset | -0.82 | |||
Operating Margin | (8.79) % | |||
Current Valuation | 6.58 M | |||
Shares Outstanding | 32.48 M | |||
Shares Owned By Insiders | 9.92 % | |||
Shares Owned By Institutions | 8.34 % | |||
Price To Book | 4.19 X | |||
Price To Sales | 7.96 X | |||
Revenue | 236.04 K | |||
Gross Profit | (276.83 K) | |||
EBITDA | (16.08 M) | |||
Net Income | (15.95 M) | |||
Cash And Equivalents | 481.83 K | |||
Cash Per Share | 0.02 X | |||
Total Debt | 1.62 M | |||
Debt To Equity | 1.13 % | |||
Current Ratio | 0.46 X | |||
Book Value Per Share | 0.06 X | |||
Cash Flow From Operations | (8.59 M) | |||
Earnings Per Share | (0.56) X | |||
Target Price | 10.04 | |||
Number Of Employees | 43 | |||
Market Capitalization | 13.25 M | |||
Total Asset | 6.88 M | |||
Z Score | -1.8 | |||
Net Asset | 6.88 M |
About Awakn Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Awakn Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Awakn Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Awakn Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. Awakn Life is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Awakn OTC Stock
Awakn Life financial ratios help investors to determine whether Awakn OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Awakn with respect to the benefits of owning Awakn Life security.